🇺🇸 FDA

Company profile · Sponsor

Children's

Children's Hospital of Fudan University

C330DCA · NMPA pharma CN
Pipeline
20
Drugs
0
Patents
0

Quick answer

Children's (C330DCA) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 20 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C330DCA
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (20)

Search pipeline →

  1. Asparaginase

    Children's

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  2. Cisplatin

    Children's

    Localized Osteosarcoma

    phase 3 small molecule completed

    1 trial

  3. Cyclophosphamide

    Children's

    Stage III Kidney Wilms Tumor

    phase 3 small molecule active

    1 trial

  4. Dactinomycin

    Children's

    Adult Kidney Wilms Tumor

    phase 3 mab active

    1 trial

  5. asparaginase

    Children's

    Leukemia

    phase 3 small molecule completed

    2 trials

  6. cyclosporine

    Children's

    Graft Versus Host Disease

    phase 3 small molecule completed

    1 trial

  7. dactinomycin

    Children's

    Kidney Cancer

    phase 3 mab completed

    1 trial

  8. doxorubicin hydrochloride

    Children's

    Adult Alveolar Soft-part Sarcoma

    phase 3 small molecule completed

    1 trial

  9. filgrastim

    Children's

    Neuroblastoma

    phase 3 mab completed

    1 trial

  10. Busulfan

    Children's

    Juvenile Myelomonocytic Leukemia

    phase 2 small molecule completed

    1 trial

  11. Carboplatin

    Children's

    Desmoplastic/Nodular Medulloblastoma

    phase 2 small molecule completed

    1 trial

  12. Carboplatin

    Children's

    Central Nervous System Nongerminomatous Germ Cell Tumor

    phase 2 small molecule completed

    1 trial

  13. Dinutuximab

    Children's

    High Risk Neuroblastoma

    phase 2 mab active

    1 trial

  14. Doxorubicin Hydrochloride

    Children's

    Childhood Renal Cell Carcinoma

    phase 2 small molecule completed

    1 trial

  15. bleomycin sulfate

    Children's

    Childhood Germ Cell Tumor

    phase 2 mab completed

    1 trial

  16. radiation therapy

    Children's

    Brain Tumor

    phase 2 other completed

    1 trial

  17. rituximab

    Children's

    Lymphoproliferative Disorder

    phase 2 mab completed

    1 trial

  18. temozolomide

    Children's

    Brain and Central Nervous System Tumors

    phase 2 small molecule completed

    1 trial

  19. imatinib mesylate

    Children's

    Leukemia

    phase 1 small molecule completed

    1 trial

  20. Misoprostol

    Children's

    Postpartum Hemorrhage

    small molecule completed

    1 trial

Frequently asked questions

What is Children's?

Children's (C330DCA) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 20 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Children's sponsor?

We track 20 ClinicalTrials.gov-linked programs for Children's, including Asparaginase and 19 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Children's company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.